✦ LIBER ✦

Intravenous octreotide test predicts the long term outcome of treatment with octreotide-long-acting repeatable in active acromegaly

✍ Scribed by Nienke R. Biermasz; Alberto M. Pereira; Jan W.A. Smit; Johannes A. Romijn; Ferdinand Roelfsema

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Acting Octreotide LAR Compared with

✍ Pat Kendall-Taylor; Margaret Miller; Janice Gebbie; Steve Turner; Masoud Al-Mask 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 94 KB

Octreotide Long-Acting Repeatable for th

✍ Tom Missotten; Jan A.M. van Laar; Theo L. van der Loos; Paul L.A. van Daele; Rob 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 366 KB

Four-Year Treatment with Octreotide-Long

✍ Cozzi, Renato; Attanasio, Roberto; Montini, Marcella; Pagani, Giorgio; Lasio, Gi 📂 Article 📅 2003 🏛 Endocrine Society 🌐 English ⚖ 232 KB

A prospective, multicentre study to inve

✍ Moises Mercado; Fatima Borges; Hakim Bouterfa; Tien-Chun Chang; Alberto Chervin; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 332 KB

Octreotide LAR treatment of acromegaly i

✍ Espinosa-de-los-Monteros, Ana Laura; Gonzalez, Baldomero; Vargas, Guadalupe; Sos 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 436 KB

The value of an acute octreotide suppres

✍ Niki Karavitaki; Ileana Botusan; Serban Radian; Mihail Coculescu; Helen E. Turne 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB